1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Comparison of study variables for FCD types I and II (n = 181)
Variable FCD Type I (n = 102) FCD Type II (n = 79) P Value
Age at surgery (mean) (yr) 16.54 ± 10.76 18.11 ± 11.05 .338
Age of onset (mean) (yr) 8.29 ± 7.88 7.76 ± 7.31 .655
Duration of epilepsy (mean) (%) 9.08 ± 6.91 10.82 ± 7.60 .117
Women (%) 50 (49.0%) 40 (50.6%) .881
Multilobar distribution of FCD (%) 21 (20.6%) 3 (3.8%) <.001
Febrile convulsions (%) 12 (11.9%) 9 (11.4%) 1.000
Multiple types of seizures (%) 31 (30.4%) 19 (24.1%) .403
Delayed development (%) 32 (31.4%) 13 (16.5%) .025
Daily seizures (%) 57 (55.9%) 48 (60.8%) .546
Aura (%) 18 (17.6%) 23 (29.1%) .076
Regional ictal EEG onset pattern (%) 40 (39.2%) 45 (58.4%) .024
Clear-cut FCD on MRI (%) 62 (60.8%) 67 (84.8%) <.001
Focal FDG-PET pattern (%) 77 ( (75.5%) 63 (79.7%) .592
Focal ictal SPECT pattern (%) 48 (70.6%) 29 (72.5%) 1.000
Eloquent cortex location (%) 21 (20.6%) 15 (19.0%) .852
Seizure-free (%) 57 (55.8%) 63 (79.7%) .008
Acute postoperative seizures (%) 38 (37.3%) 24 (30.4%) .348
Complete resection (%) 63 (77.8%) 65 (90.3%) .048